The report analyzes and
presents an overview of "
EpiCast
Report: Idiopathic Pulmonary Fibrosis
- Epidemiology Forecast to 2022 "worldwide
Market outlook of the
protein therapeutics market
Technavios market research
analyst predicts the global protein therapeutics market to grow
steadily at a CAGR of 8% during the forecast period. Increased demand
for and use of monoclonal antibodies is expected to drive the growth
of the protein therapeutics market as it accounts for more than half
of the protein therapeutics market. The monoclonal antibodies can be
prepared specific to any cell surface or extracellular target. These
antibodies are being used in radioimmunotherapy and antibody-directed
enzyme prodrug therapy. Monoclonal antibodies are also used in the
formulation of various biopharmaceutical drugs for the treatment of
different diseases such as cancer, rheumatoid arthritis, multiple
sclerosis, and UC.
The availability of favorable
reimbursement policies in this market is expected to boost the market
growth during the forecast period. Protein therapeutics are expensive
and cannot be afforded by all, but reimbursement of the diagnostic
kits and biologic drugs are expected to fuel the market during the
forecast period. Plans like the public reimbursement programs reduce
the financial burden of treatments. The reimbursement status of drugs
varies from region to region, with factors such as lack of
cost-effectiveness impeding the coverage.
Download Sample copy of
this Report@
http://www.marketresearchreports.biz/sample/sample/166497
Scope
- The Idiopathic Pulmonary Fibrosis (IPF) EpiCast Report provides an overview of the risk factors and global trends of IPF in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK).
- It includes a 10-year epidemiology forecast of the incident and prevalent cases of IPF segmented by sex and age (by five-year increments, beginning at age 50 years and ending at age 85 years and older) in the 6MM.
Reasons
to buy
- Develop business strategies by understanding the trends shaping and driving the global IPF market.
- Quantify patient populations in the global IPF market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for IPF therapeutics in each of the markets covered.
Browse
All reports Of this
Category:http://www.marketresearchreports.biz/category/38
Table
of Content :
Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and
Comorbidities 10
3.2.1 There is almost no risk
of IPF among long-term heavy smokers 11
3.2.2 Common workplace
inhalant pose a large risk in many occupations 11
3.2.3 Gastroesophageal reflux
(GER) is common in IPF patients 12
3.3 Global Trends 13
3.3.1 US 13
3.3.2 5EU 14
3.4 Forecast Methodology 15
Explore All Published
Reports by QYResearch :
http://www.marketresearchreports.biz/publisher/1
About us
MarketResearchReports.biz is
the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact us:
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free:
866-997-4948
No comments:
Post a Comment